Yahoo Finance: Mays Cancer Center researcher and SignalRx earn NCI business grants to develop drugs for first-in-human clinical trials

Dr. Daruka Mahadevan, MD, PhD, division chief of hematology and medical oncology, and Dr. Ruben Mesa, MD, FACP, executive director of Mays Cancer Center, are quoted in this story.

Read more

Share This Article!